Market Insights Health Pharmaceuticals Vaccines

COVID-19 Vaccines - Sudan

Sudan

In Sudan, the revenue in the COVID-19 Vaccines market is forecasted to reach US$102.40m in 2024.
It is expected that the revenue will exhibit an annual growth rate (CAGR 2024-2029) of -19.74%, leading to a market volume of US$34.11m by 2029.
When compared globally, United States is projected to generate the highest revenue of US$4,389,000.00k in 2024.
Sudan has seen a surge in demand for COVID-19 vaccines, as the government strives to vaccinate its population and curb the spread of the virus.

Key regions: United Kingdom, Germany, France, South Korea, Italy

Market

Region

Region comparison

Currency

Analyst Opinion

The COVID-19 pandemic has had a significant impact on the global healthcare industry, particularly in the development and distribution of vaccines. Sudan, a country in North Africa, has also been affected by the pandemic and has seen a rise in the demand for COVID-19 vaccines.

Customer preferences: The people of Sudan have shown a growing interest in COVID-19 vaccines due to the increasing number of cases and deaths in the country. The government has taken steps to increase awareness about the importance of vaccines and has also made efforts to provide vaccines to its citizens. The majority of the population in Sudan prefers vaccines that have been approved by the World Health Organization (WHO) and are considered safe and effective.

Trends in the market: The COVID-19 vaccines market in Sudan is still in its early stages, with limited availability of vaccines. However, there has been a significant increase in the demand for vaccines, which has led to an increase in the number of vaccine providers in the country. The government has also been working to secure more vaccines from different sources to meet the growing demand.

Local special circumstances: Sudan has a unique set of circumstances that have affected the availability and distribution of vaccines. The country has been facing political instability and economic challenges for several years, which has made it difficult to invest in the healthcare sector. The recent removal of Sudan from the US list of state sponsors of terrorism has opened up opportunities for the country to receive more aid and investments, including in the healthcare sector.

Underlying macroeconomic factors: The COVID-19 pandemic has had a significant impact on the global economy, and Sudan is no exception. The country has been facing economic challenges for several years, which have been exacerbated by the pandemic. The government has been working to secure more aid and investments to support the healthcare sector, including the development and distribution of vaccines. The recent removal of Sudan from the US list of state sponsors of terrorism has also opened up opportunities for the country to receive more aid and investments. In conclusion, the COVID-19 vaccines market in Sudan is still in its early stages, but there has been a significant increase in demand for vaccines. The government has taken steps to increase awareness and provide vaccines to its citizens, and there has been an increase in the number of vaccine providers in the country. Sudan's unique circumstances, including political instability and economic challenges, have affected the availability and distribution of vaccines, but the recent removal of Sudan from the US list of state sponsors of terrorism has opened up opportunities for the country to receive more aid and investments in the healthcare sector.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.